2 withdrawn. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Withdrawn 2 |
| Phase 2 | 1 | Withdrawn 1 |
Follow Skin Abnormalities: new trials by email Literature Review of Skin Abnormalities trials Research Report on Skin Abnormalities
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Ultrasound-Guided Dextrose Prolotherapy in Ehlers-Danlos Syndrome Patients Dextrose 50% Intravenous Solution, Lidocaine 1% Injectable Solution - Ehlers-Danlos Syndrome, Low Back Pain | Phase 3 | Withdrawn | Tulane University | 2026-10-05 | 2026-10-08 | |
| The Efficacy and Safety of 3% Cannabidiol (CBD) Cream in Patients With Epidermolysis Bullosa: A Phase II/III Trial AVCN583601 (3% Cannabidiol cream) - Epidermolysis Bullosa, Pain | Phase 2 / Phase 3 | Withdrawn | Elena Pope | 2020-08-01 | 2021-06-18 |
Ehlers-Danlos Syndrome (1) · Epidermolysis Bullosa (1) · Low Back Pain (1) · Pain (1) · Pruritus (1)
Congenital Abnormalities (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Genetic Diseases, Inborn (2) · Neurologic Manifestations (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Skin Diseases (2) · Skin Diseases, Genetic (2) · Skin and Connective Tissue Diseases (2) · Back Pain (1) · Cardiovascular Diseases (1) · Collagen Diseases (1) · Connective Tissue Diseases (1) · Hematologic Diseases (1)
Elena Pope (1) · Tulane University (1)
Canada (1)
Elena Pope, MD (1) · Jacques Courseault, MD (1)